A Phase 3, Open-label Study of the Safety and Effectiveness of AA4500 Administered Twice Per Treatment Cycle for up to Four Treatment Cycles (2 x 4) in Men With Peyronie's Disease
Clinical trial NCT01685437 · COMPLETED
Trial details
- NCT number
- NCT01685437
- Sponsor
- Endo USA Inc., a Keenova Therapeutics Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-09-01
- Primary completion
- 2013-12-01
- Enrollment
- 189
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.